Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)

China flag China · Delayed Price · Currency is CNY
30.25
-0.14 (-0.46%)
Apr 25, 2025, 2:45 PM CST
-40.23%
Market Cap 8.05B
Revenue (ttm) 1.36B
Net Income (ttm) 99.20M
Shares Out 266.36M
EPS (ttm) 0.37
PE Ratio 80.76
Forward PE 27.40
Dividend n/a
Ex-Dividend Date n/a
Volume 2,788,100
Average Volume 4,644,693
Open 31.24
Previous Close 30.39
Day's Range 30.07 - 31.24
52-Week Range 26.61 - 56.77
Beta -0.41
RSI 42.91
Earnings Date Apr 22, 2025

About SHE:300049

Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. It operates in two segments, pharmaceutical production and sales; and diagnostic equipment R&D, production and sales. The pharmaceutical production and sales segment produces and sells products, such as Fufang Biejiaruangan tablets and shell fat capsules. The diagnostic equipment R&D, production and sales segment develops, produces, and sells the FibroScan series of liver fibrosis diagnostic instruments. It pro... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 703
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300049
Full Company Profile

Financial Performance

In 2024, SHE:300049's revenue was 1.35 billion, an increase of 16.93% compared to the previous year's 1.15 billion. Earnings were 113.29 million, an increase of 11.54%.

Financial Statements

News

There is no news available yet.